IREDAYO LTD

Company number 14519097 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

IREDAYO LTD - Analysis Report

Company Number: 14519097

Analysis Date: 2025-07-29 16:43 UTC

  1. Risk Rating: HIGH
    The company exhibits a negative net asset position and net current liabilities, indicating a solvency risk. Given the micro-entity status and limited financial data, there is a significant concern about the company's ability to meet its obligations.

  2. Key Concerns:

  • Negative Net Assets: The balance sheet shows net assets of -£3,106, implying the company’s liabilities exceed its assets.
  • Negative Net Current Assets: Current liabilities (£13,493) exceed current assets (£327) by £13,166, suggesting liquidity issues and potential cash flow constraints.
  • Limited Operational Scale: With only one employee and minimal current assets, the company may lack operational stability and resilience to financial stress.
  1. Positive Indicators:
  • Compliance with Filing Requirements: No overdue accounts or confirmation statements, indicating good regulatory compliance and governance at present.
  • Sole Director and Shareholder: Mrs. Latifat Olofin has full control, which may facilitate swift decision-making.
  • Micro-entity Status: This suggests a small operational scale, which can sometimes limit exposure to large liabilities or operational complexity.
  1. Due Diligence Notes:
  • Investigate the nature and timing of current liabilities to assess if they are trade payables, loans, or other obligations and their payment terms.
  • Review cash flow statements if available to understand liquidity management and sources of cash.
  • Assess business model viability and revenue streams given the micro-entity scale and industry classification (other human health activities).
  • Confirm if any contingent liabilities or off-balance-sheet risks exist that might exacerbate financial stress.
  • Evaluate director’s plans or capital injection prospects to improve solvency and liquidity.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.